| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |